Neogenix Oncology Inc

company.status.inactive

CIK 1341293fmd_19S4Y5A2YS3P77587J1RXW6C4TManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2004 to Dec 31, 2011, 12 periods

Ratios computed from the standardized statements. Select a value to open its proof.